Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease - The Lancet Healthy Longevity
The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review | Journal of Nuclear Medicine
Neuroimmune Connections in Aging and Neurodegenerative Diseases: Trends in Immunology
Blood Tests for Alzheimer Disease - Practical Neurology
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study - The Lancet
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Recognizing Subtle Signs of Early Stage Neurodegeneration - Holistic Primary Care
Frontiers | Re-thinking the Etiological Framework of Neurodegeneration
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? | Insights into Imaging | Full Text
Biomarker Development: A Tool to Prevent Neurodegenerative Disorders | UC Davis Biotechnology Program
Cerebrospinal fluid biomarkers to monitor treatment effects in Alzheimer's disease and related conditions
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Biomarkers in vascular dementia: A recent update - ScienceDirect
SQSTM1/p62: A Potential Target for Neurodegenerative Disease | ACS Chemical Neuroscience
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Biomarkers for neurodegenerative diseases | Nature Medicine
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease | PLOS ONE
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Biomarkers for neurological disorders – call for standardization
Physiological changes in neurodegeneration — mechanistic insights and clinical utility | Nature Reviews Neurology
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay | Molecular Neurodegeneration | Full Text
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia | Journal of Neurology, Neurosurgery & Psychiatry
Biomarkers for neurodegenerative diseases | Nature Medicine
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. - Abstract - Europe PMC
Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
